Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU.
about
Innovative regenerative medicines in the EU: a better future in evidence?Lessons learned on the design and the conduct of Post-Authorization Safety Studies: review of 3 years of PRAC oversight.An analysis of characteristics of post-authorisation studies registered on the ENCePP EU PAS Register.Publication of confirmatory studies required by Health Canada for drugs approved under a Notice of Compliance with conditions: a cohort study.Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study.
P2860
Q36300179-0ECD7095-AD99-42EC-812C-8B96582104D6Q38990529-261C0329-2F83-44BA-B540-12A7FD3CC7D2Q47105595-5FB97F76-7CA7-4E41-BAF8-F7B3329AA273Q47141821-9D0AC4EE-CCD8-452F-8A49-8B9AD147194EQ49318188-44310431-F3E0-4D2C-A6A5-49595F8F5164Q52679541-2CE267D6-D24A-4EF1-918B-F08DE359877AQ53282175-DA0575C2-FE40-4269-ACF4-8BACDA8C4BF6
P2860
Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Characteristics and follow-up ...... uthorized medicines in the EU.
@en
Characteristics and follow-up ...... uthorized medicines in the EU.
@nl
type
label
Characteristics and follow-up ...... uthorized medicines in the EU.
@en
Characteristics and follow-up ...... uthorized medicines in the EU.
@nl
altLabel
Characteristics and follow-up ...... authorized medicines in the EU
@en
prefLabel
Characteristics and follow-up ...... uthorized medicines in the EU.
@en
Characteristics and follow-up ...... uthorized medicines in the EU.
@nl
P2093
P2860
P356
P1476
Characteristics and follow-up ...... authorized medicines in the EU
@en
P2093
Aukje K Mantel-Teeuwisse
Hubert G M Leufkens
Jarno Hoekman
Thea T Klamer
P2860
P304
P356
10.1111/BCP.12940
P407
P50
P577
2016-04-22T00:00:00Z